ENABLE-1 (Toll-like receptor signaling enhancement for B-cell lymphoma CAR-T therapy)

· Malaghan Institute of Medical Research

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ENABLE-1 (Toll-like receptor signaling enhancement for B-cell lymphoma CAR-T therapy), covering 2024-08-21 to 2024-08-21. Get the full timeline:

Most recent: Clinical Trial Update: ENABLE-1 (Engaging Toll-like Receptor Signalling for B-cell Lymphoma Chimeric Antigen Receptor Therapy) [Phase 1]

See pricing